Literature DB >> 2148875

Cells secreting tumour necrosis factor show enhanced metastasis in nude mice.

S T Malik1, M S Naylor, N East, A Oliff, F R Balkwill.   

Abstract

A tumour cell may acquire the ability to invade and metastasise via heritable changes in its genome and/or changes in the local environment. Chinese hamster ovary (CHO) cells transfected with the gene for human TNF (CHO/TNF cells) showed a greatly enhanced ability to invade peritoneal surfaces and metastasise in nude mice compared with cells transfected by the vector alone. In situ hybridisation with a riboprobe for human TNF showed that the CHO/TNF cells were actively transcribing this cytokine after in vivo injection. Neutralising antibodies to human TNF, both whole IgG and F(ab)2 fragments, abrogated the enhanced metastatic activity of the TNF-secreting cells. Thus transfection of a cytokine/growth-factor gene can confer a metastatic phenotype on the recipient cell.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2148875     DOI: 10.1016/0277-5379(90)90044-t

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  38 in total

1.  Cytokines and cancer.

Authors:  S Malik; J Waxman
Journal:  BMJ       Date:  1992-08-01

2.  IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1.

Authors:  F Vidal-Vanaclocha; G Fantuzzi; L Mendoza; A M Fuentes; M J Anasagasti; J Martín; T Carrascal; P Walsh; L L Reznikov; S H Kim; D Novick; M Rubinstein; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

3.  Tumour necrosis factor-alpha stimulates invasiveness of T-cell hybridomas and cytotoxic T-cell clones by a pertussis toxin-insensitive mechanism.

Authors:  G La Rivière; J W Klein Gebbinck; C A Schipper; E Roos
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

4.  Heterogeneous Enhancement Patterns of Tumor-adjacent Parenchyma at MR Imaging Are Associated with Dysregulated Signaling Pathways and Poor Survival in Breast Cancer.

Authors:  Jia Wu; Bailiang Li; Xiaoli Sun; Guohong Cao; Daniel L Rubin; Sandy Napel; Debra M Ikeda; Allison W Kurian; Ruijiang Li
Journal:  Radiology       Date:  2017-07-14       Impact factor: 11.105

5.  Tumor necrosis factor-α is associated with positive lymph node status in patients with recurrence of colorectal cancer-indications for anti-TNF-α agents in cancer treatment.

Authors:  M Grimm; M Lazariotou; S Kircher; A Höfelmayr; C T Germer; B H A von Rahden; A M Waaga-Gasser; M Gasser
Journal:  Cell Oncol (Dordr)       Date:  2011-08       Impact factor: 6.730

6.  Expression of matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) induced by tumour necrosis factor alpha correlates with metastatic ability in a human osteosarcoma cell line.

Authors:  A Kawashima; I Nakanishi; H Tsuchiya; A Roessner; K Obata; Y Okada
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 7.  Tumor-host interactions: the role of inflammation.

Authors:  Marie-Aude Le Bitoux; Ivan Stamenkovic
Journal:  Histochem Cell Biol       Date:  2008-10-25       Impact factor: 4.304

8.  TNF-α increases the membrane expression of the chemokine receptor CCR6 in thyroid tumor cells, but not in normal thyrocytes: potential role in the metastatic spread of thyroid cancer.

Authors:  Francesca Coperchini; Patrizia Pignatti; Andrea Carbone; Rossana Bongianino; Christian A Di Buduo; Paola Leporati; Laura Croce; Flavia Magri; Alessandra Balduini; Luca Chiovato; Mario Rotondi
Journal:  Tumour Biol       Date:  2015-11-17

9.  Radiofrequency thermal ablation with expandable needle of focal liver malignancies: complication report.

Authors:  Elisabetta Buscarini; Luigi Buscarini
Journal:  Eur Radiol       Date:  2003-10-17       Impact factor: 5.315

10.  Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells.

Authors:  Navdeep Chehl; Galina Chipitsyna; Qiaoke Gong; Charles J Yeo; Hwyda A Arafat
Journal:  HPB (Oxford)       Date:  2009-08       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.